NCT02224339View on ClinicalTrials.gov

New Technologies to Determine Carotid Plaque Vulnerability

CompletedOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2018

Study Completion Date

January 31, 2019

Conditions
AtherosclerosisCarotid Artery Plaque
Trial Locations (1)

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Mayo Clinic

OTHER

NCT02224339 - New Technologies to Determine Carotid Plaque Vulnerability | Biotech Hunter | Biotech Hunter